{"public_id":"co_237d13ac1ce5d90411ee3a96c787d998","status":"active","merged_into_public_id":null,"resolved_public_id":"co_237d13ac1ce5d90411ee3a96c787d998","name":"breast cancer","description":"A malignancy of breast tissue examined as a site-specific cancer outcome in women with T2DM.","aliases":[],"types":["condition"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":3,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":53749526,"title":"Cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data","citation_count":13,"url":"https://sah.borca.ai/papers/53749526"}],"claims":[{"public_id":"cl_87c88fa7d8d7e53957f5fdcdfcae3bd0","text":"After the first year of follow-up, overall cancer risk in the type 2 diabetes cohort was reduced relative to the general population (SIR 0.80, 95% CI 0.76-0.85 in men; SIR 0.93, 95% CI 0.88-0.99 in women), while women retained elevated risks of breast cancer (SIR 1.13, 95% CI 1.01-1.28) and thyroid cancer (SIR 1.37, 95% CI 1.11-1.63).","corpus_id":53749526,"url":"https://sah.borca.ai/claims/cl_87c88fa7d8d7e53957f5fdcdfcae3bd0"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_237d13ac1ce5d90411ee3a96c787d998","url":"https://sah.borca.ai/concepts/co_237d13ac1ce5d90411ee3a96c787d998"}